Related Experiment Videos
Lectin binding patterns of human tissue mast cells indicate marked phenotypical diversity
U Schumacher1, H P Horny, U Welsch
1Human Morphology, University of Southampton, UK.
Acta Histochemica
|January 1, 1991
Summary
Human tissue mast cells (MCs) show diverse glycoconjugate expression. Lectin binding varied across disease states but did not differentiate between reactive and tumorous MCs, indicating phenotypical diversity.
Area of Science:
- Histochemistry
- Immunology
- Glycobiology
Background:
- Mast cells (MCs) are immune cells involved in allergic reactions and inflammation.
- Understanding mast cell heterogeneity is crucial for diagnosing and treating mast cell-related disorders.
- Glycoconjugate expression on mast cells can reflect their functional state and origin.
Purpose of the Study:
- To investigate the glycoconjugate expression profile of human tissue mast cells.
- To determine if lectin binding patterns can differentiate mast cells from various pathological conditions.
- To explore the phenotypical diversity of mast cells based on their surface glycoconjugates.
Main Methods:
- Histochemical analysis of human mast cells from lymph nodes, skin lesions (urticaria pigmentosa), and bone marrow (systemic mastocytosis).
- Application of a broad panel of 19 fluorescein-labeled lectins with specificities for fucose, N-acetylgalactosamine, neuraminic acid, mannose, N-acetylglucosamine, and galactose.
- Evaluation of lectin binding patterns and intensity across different disease entities.
Main Results:
- Eleven out of 19 lectins showed no binding to mast cells.
- Eight lectins, specific for mannose, N-acetylglucosamine, and galactose, bound to mast cells.
- Lectin binding patterns varied among different disease conditions, but no lectin distinguished between reactive and tumorous mast cells.
Conclusions:
- Human tissue mast cells exhibit significant phenotypical diversity in their lectin-binding properties.
- Lectin histochemistry is not suitable for differentiating between reactive and neoplastic mast cell proliferations.
- Further research into mast cell glycoconjugates may reveal novel diagnostic or therapeutic targets.